Drug
Prulifloxacin clinical trials
How studies write it
Studies that test it under each name
Name
- prulifloxacin
- 5
Studies by the year they started
6 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 1
Lee's Pharmaceutical Limited (2) · Aziende Chimiche Riunite Angelini Francesco S.p.A (1) · Merck Sharp & Dohme LLC (1) · Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1) · University Of Perugia (1)
Studies
Open first, then newest update. How each study uses prulifloxacin is read from its arms, and is right about nine times in ten.
Testing it · 6
- Prulifloxacin in Chronic Bacterial Prostatitis (CBP)CompletedPhase 2Aziende Chimiche Riunite Angelini Francesco S.p.ANCT03201796Written as Prulifloxacin 600 mg
- A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection With Levofloxacin Hydrochloride Tablet as Active ControlCompletedPhase 3Lee's Pharmaceutical LimitedNCT02439632Written as prulifloxacin
- Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's DiarrheaCompletedPhase 3Merck Sharp & Dohme LLCNCT00392574Written as Prulifloxacin
- A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Exacerbations of Chronic Bronchitis With Levofloxacin Hydrochloride Tablet as Active ControlStatus unknownPhase 3Lee's Pharmaceutical LimitedNCT02157571Written as Prulifloxacin
- Efficacy of Two Prophylactic Schedules (Prulifloxacin Versus Phosphomycin)Status unknownPhase 2University Of PerugiaNCT01231737Written as prulifloxacin
- Safety and Efficacy of Prulifloxacin vs Placebo in Treatment of Acute Gastroenteritis in Adult TravelersCompletedPhase 3Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)NCT00448422Written as prulifloxacin
Codes
What other systems call prulifloxacin · ClinicalTrials.gg INT003626
- MeSH (NLM) C074191prulifloxacinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) J42298IESWPRULIFLOXACINConfirmed FDA, NLM, Wikidata
- Wikidata Q3924793prulifloxacinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C72637PrulifloxacinOne source FDA
- DrugBank DB11892One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C074191 | prulifloxacin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | J42298IESW | PRULIFLOXACIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q3924793 | prulifloxacin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C72637 | Prulifloxacin | One source FDA |
| DrugBank | DB11892 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.